26 /100
MEDIUM RISK
Score updated May 30, 2026

PRLD — Prelude Therapeutics Incorporated Dilution Risk Tracker

Track PRLD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PRLD — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
60
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
7%
🔄 Reverse Split 15%
• 52-week low $0.75 has breached $1
🔔 Track PRLD — Get forecast alerts →

💹 Market Data

Market Cap$312.21M
Shares Outstanding64.92M
Float22.96M
Cash$81.55M
Debt$17.72M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 11.8% shares (2025Q4 vs prior)
48 institutional holders · 30.62M shares
#1 ORBIMED ADVISORS LLC 10.91M shares
#2 BAKER BROS. ADVISORS LP 10.12M shares
#3 Boxer Capital Management, LLC 2.11M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.85M
Days to Cover3.5
% of Float8.1%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2020
3 FORM3 Apr 15, 2026
3 FORM3 Mar 19, 2026
8-K 8K EVENT Mar 12, 2026
424B5 ATM Mar 12, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track PRLD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PRLD — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for PRLD
📊 PRLD FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PRLD Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.